BlackRock’s enVVeno Medical NVNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$229K Buy
57,404
+17,275
+43% +$68.9K ﹤0.01% 4562
2025
Q1
$106K Sell
40,129
-495
-1% -$1.3K ﹤0.01% 4709
2024
Q4
$123K Buy
40,624
+165
+0.4% +$498 ﹤0.01% 4683
2024
Q3
$136K Buy
40,459
+990
+3% +$3.33K ﹤0.01% 4561
2024
Q2
$207K Buy
39,469
+1,978
+5% +$10.4K ﹤0.01% 4490
2024
Q1
$204K Sell
37,491
-650
-2% -$3.54K ﹤0.01% 4512
2023
Q4
$196K Buy
38,141
+7,062
+23% +$36.3K ﹤0.01% 4568
2023
Q3
$168K Sell
31,079
-2,624
-8% -$14.1K ﹤0.01% 4657
2023
Q2
$104K Sell
33,703
-749
-2% -$2.31K ﹤0.01% 4810
2023
Q1
$161K Buy
34,452
+642
+2% +$3.01K ﹤0.01% 4749
2022
Q4
$172K Buy
33,810
+146
+0.4% +$745 ﹤0.01% 4807
2022
Q3
$211K Buy
33,664
+254
+0.8% +$1.59K ﹤0.01% 4873
2022
Q2
$127K Sell
33,410
-5,031
-13% -$19.1K ﹤0.01% 5075
2022
Q1
$244K Buy
38,441
+1,078
+3% +$6.84K ﹤0.01% 4970
2021
Q4
$246K Buy
37,363
+18,229
+95% +$120K ﹤0.01% 4989
2021
Q3
$199K Sell
19,134
-3,296
-15% -$34.3K ﹤0.01% 4926
2021
Q2
$154K Buy
+22,430
New +$154K ﹤0.01% 4882